Healthway Cancer Care Hospital (HCCH), the first cancer specialty hospital in the Philippines, has partnered with Chang Gung Memorial Hospital (CGMH) in Taiwan to provide access to advanced cancer treatments.
This collaboration focuses on a cross-border patient referral program for advanced oncology treatments not yet available in the Philippines, such as proton beam therapy (PBT).
CGMH is a recognized leader in advanced cancer treatments in Asia, offering one of the region’s most comprehensive Proton Beam Therapy centers. The Proton and Radiation Therapy Center at CGMH Linkou is Taiwan’s first proton therapy center. This state-of-the-art facility combines cutting-edge technology with strong clinical expertise and a robust foundation in clinical research. CGMH is highly regarded for generating high-quality research and clinical outcomes data that contribute significantly to the global knowledge of PBT and cancer care.
PBT offers a highly precise way to target tumors, thereby minimizing damage to surrounding healthy tissue and reducing side effects. This added precision is particularly beneficial for treating tumors located near critical organs such as the lungs, spinal cord, heart, and brain, where damage could cause serious problems.
The signing of the Memorandum of Understanding (MOU) took place on September 17, 2025, at HCCH in Taguig City. The event brought together key leaders from both institutions.
Three-pillar approach
The partnership between HCCH and CGMH focuses on three key areas to advance cancer care-Patient Referrals, Clinical Knowledge Exchange, and Data and Outcomes Collaboration.
HCCH will refer eligible patients for proton beam therapy at CGMH with agreed protocols and supported by care coordinators on both sides to facilitate logistics and other requirements.
The collaboration will establish virtual case conferences and tumor boards, allowing physicians from both hospitals to share expertise and discuss complex patient cases.
Additionally, the partnership will facilitate clinical rotations and observership opportunities for HCCH physicians at CGMH, with a special emphasis on radiation oncology and proton beam therapy.
HCCH and CGMH will also collaborate on a joint research initiative by sharing de-identified clinical outcomes for referred patients. This will not only ensure quality assurance but also pave the way for joint research opportunities, ultimately contributing to a better understanding of cancer treatments and their effectiveness.
With the shared goal of bringing the best in cancer care to patients, CGMH now joins HCCH’s ecosystem of international partners, which includes renowned institutions like the US-based City of Hope and National Cancer Centre Singapore.